Our results revealed no significant correlation between Nrf1/2 expression levels and dynamic fluctuations of ROS or Fe2+; it is necessary to block Nrf1/2 to further verify the relationship between Nrf1/2 and ferroptosis in HCC. The gene discussed is NRF1; the disease is hepatocellular carcinoma.